Recently, Cervera et al. confirmed in murine model of middle cerebral artery occlusion the neuroprotective effects of genetic MBL deletion in the acute post-stroke but did not find improvements in either infarct volume or neurological function at 7-day examination [117]. This evidence concerns the gene MBL2 and stroke disorder.